TY - CHAP A1 - Bader, Martin A1 - Gassmann, Oliver ED - Gassmann, Oliver ED - Ferrandina, Fabrizio T1 - Patent Strategies in the Networked Economy T2 - Connected Business: Create Value in a Networked Economy UR - https://doi.org/10.1007/978-3-030-76897-3_14 Y1 - 2021 UR - https://doi.org/10.1007/978-3-030-76897-3_14 SN - 978-3-030-76897-3 SN - 978-3-030-76896-6 SP - 247 EP - 264 PB - Springer CY - Cham ER - TY - JOUR A1 - Schuhmacher, Alexander A1 - Haefner, Naomi A1 - Honsberg, Katharina A1 - Goldhahn, Jörg A1 - Gassmann, Oliver T1 - The dominant logic of Big Tech in healthcare and pharma JF - Drug Discovery Today UR - https://doi.org/10.1016/j.drudis.2022.103457 Y1 - 2022 UR - https://doi.org/10.1016/j.drudis.2022.103457 SN - 1359-6446 VL - 28 IS - 2 PB - Elsevier CY - Amsterdam ER - TY - BOOK A1 - Gassmann, Oliver A1 - Bader, Martin A1 - Thompson, Mark James T1 - Patent Management BT - Protecting Intellectual Property and Innovation T3 - Management for Professionals UR - https://doi.org/10.1007/978-3-030-59009-3 KW - Patent management KW - Intellectual property management KW - Protecting innovation KW - Patents and regulation KW - Intellectual property rights KW - Patent law Y1 - 2021 UR - https://doi.org/10.1007/978-3-030-59009-3 SN - 978-3-030-59009-3 SN - 978-3-030-59008-6 PB - Springer CY - Cham ER - TY - JOUR A1 - Schuhmacher, Alexander A1 - Hinder, Markus A1 - Boger, Nikolaj A1 - Hartl, Dominik A1 - Gassmann, Oliver T1 - The significance of blockbusters in the pharmaceutical industry JF - Nature Reviews Drug Discovery UR - https://doi.org/10.1038/d41573-022-00213-z Y1 - 2022 UR - https://doi.org/10.1038/d41573-022-00213-z SN - 1474-1784 VL - 22 IS - 3 SP - 177 EP - 178 PB - Springer Nature CY - London ER - TY - JOUR A1 - Schuhmacher, Alexander A1 - Hinder, Markus A1 - Boger, Nikolaj A1 - Gassmann, Oliver A1 - Hartl, Dominik T1 - Is the blockbuster imperative broken? JF - Drug Discovery Today UR - https://doi.org/10.1016/j.drudis.2023.103789 Y1 - 2023 UR - https://doi.org/10.1016/j.drudis.2023.103789 SN - 1359-6446 VL - 28 IS - 11 PB - Elsevier CY - Amsterdam ER - TY - CHAP A1 - Bader, Martin A1 - Gassmann, Oliver ED - Hinder, Markus ED - Schuhmacher, Alexander ED - Goldhahn, Jörg ED - Hartl, Dominik T1 - Patents in the Biomedical Sciences and Industry – The Case of the Swiss Life Science Company Prionics T2 - Principles of Biomedical Sciences and Industry: Translating Ideas into Treatments UR - https://doi.org/10.1002/9783527824014.ch16 Y1 - 2022 UR - https://doi.org/10.1002/9783527824014.ch16 SN - 978-3-527-34571-7 SN - 978-3-527-82399-4 SP - 305 EP - 315 PB - Wiley-VCH CY - Weinheim ER - TY - JOUR A1 - Schuhmacher, Alexander A1 - Gassmann, Oliver A1 - Bieniok, Doria A1 - Hinder, Markus A1 - Hartl, Dominik T1 - Open innovation: A paradigm shift in pharma R&D? JF - Drug Discovery Today UR - https://doi.org/10.1016/j.drudis.2022.05.018 Y1 - 2022 UR - https://doi.org/10.1016/j.drudis.2022.05.018 SN - 1878-5832 VL - 27 IS - 9 SP - 2395 EP - 2405 PB - Elsevier CY - Amsterdam ER - TY - JOUR A1 - Bonakdar, Amir A1 - Frankenberger, Karolin A1 - Bader, Martin A1 - Gassmann, Oliver T1 - Capturing value from business models: the role of formal and informal protection strategies JF - International Journal of Technology Management UR - https://doi.org/10.1504/IJTM.2017.083073 KW - business models KW - business model innovation KW - intellectual property management KW - IPM KW - value capture KW - formal strategies KW - informal strategies KW - IP protection strategies KW - profiting from innovation Y1 - 2017 UR - https://doi.org/10.1504/IJTM.2017.083073 SN - 1741-5276 VL - 73 IS - 4 SP - 151 EP - 175 PB - Inderscience CY - Cointrin ER -